City Therapeutics Appoints Andrew Orth As Chief Executive Officer
01/07/25, 5:32 PM
Location
cambridgeIndustry
therapeutics
biotechnology
health care
Position
chief executive officer
director
City Therapeutics, Inc announced the appointment of Andrew “Andy” Orth as chief executive officer and director. With more than 25 years of experience in biopharmaceutical research, development, and commercialization, Mr Orth will lead the company as it advances into the clinical and commercial stages of development, focusing on breakthrough therapeutic innovations for a range of diseases.
Company Info
Location
cambridge, massachusetts, united states
Additional Info
City Therapeutics is a biopharmaceutical company harnessing next-generation engineering of RNAi trigger molecules to improve and expand the reach of RNAi-based medicines. The company is building a pipeline of innovative RNAi therapeutics to make a significant impact for patients across multiple therapeutic areas. Co-founded by pioneering executives and scientists in RNAi, City Therapeutics is based in Cambridge, MA, and has raised $135 million from leading life sciences investors.